---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-116128"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2025-11-28T23:59:59+00:00"
generated_at: "2026-05-16T16:05:01.659527+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HeartSciences amends equity plan to 1.25M shares, grants 70K restricted shares to CEO and RSUs to other officers

## Summary
- Board approved Amendment No. 3 to 2023 Equity Incentive Plan, increasing authorized shares from 1M to 1.25M plus annual evergreen.
- CEO Andrew Simpson granted 70,000 restricted shares; COO Mark Hilz 45,000 RSUs; CFO Danielle Watson 15,000 RSUs; each non-employee director 15,000 RSUs.
- Equity awards vest over 2-3 years with continued service; accelerated vesting if Company reaches $250K+ revenue in any future fiscal quarter.
- Amendment and grants conditioned on shareholder approval of Plan Amendment at next annual meeting.

## SEC filing metadata
- accession: 0001213900-25-116128
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2025-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390025116128/0001213900-25-116128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390025116128/ea0267735-8k_heartsci.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-116128
- JSON: https://secwatch.observer/filing/0001213900-25-116128.json
- Plain text: https://secwatch.observer/filing/0001213900-25-116128.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.